Significant Predictors | Â | Univariate analysis | ||
---|---|---|---|---|
β | 95% CI | P value | R2 | |
Characteristics | Â | Â | Â | Â |
 Gender | -0.143 | -0.281, -0.009 | 0.037 | 0.021 |
 Age (year-old) | -0.146 | -0.284, -0.012 | 0.033 | 0.021 |
 Education | 0.182 | 0.050, 0.326 | 0.01 | 0.031 |
 Psychiatric history | 0.222 | 0.09, 0.354 | 0.001 | 0.049 |
 Diabetes | -0.138 | -0.276, -0.004 | 0.037 | 0.014 |
Psychological measurements | Â | Â | Â | Â |
 Family support | -0.273 | -0.401, -0.141 | < 0.001 | 0.074 |
 Quality of life (EQ-VAS) | -0.263 | -0.404, -0.136 | < 0.001 | 0.069 |
 Cognitive (FACT-Cog total score) | -0.295 | -0.419, -0.164 | < 0.001 | 0.087 |
  Perceived cognitive impairments | -0.345 | -0.456, -0.21 | < 0.001 | 0.119 |
  Comments from others | -0.146 | -0.298, -0.012 | 0.033 | 0.021 |
  Impact on quality of life | -0.304 | -0.469, -0.189 | < 0.001 | 0.092 |
 Depression (PHQ-9) | 0.561 | 0.439, 0.659 | < 0.001 | 0.314 |
 PTSS (SPAN) | 0.526 | 0.39, 0.61 | < 0.001 | 0.276 |
 CRF (BFI) | 0.437 | 0.315, 0.559 | < 0.001 | 0.191 |
Endocrine assessment | Â | Â | Â | Â |
 DHEA | 0.286 | 0.099, 0.462 | 0.003 | 0.082 |
 DHEA-S | 0.239 | 0.05, 0.418 | 0.013 | 0.057 |